Management of Heart Failure

Authors:

Abstract
Since the 2017 publication of the ACC/AHA/HFSA focused update of HF guidelines, multiple clinical trials have demonstrated the significant benefits of novel medical therapies for patients with HF across the spectrum of EF.1-4 The emergence of these therapies adds nuance and complexity to the care of patients with HF.

This publication has 10 references indexed in Scilit: